cephalothin has been researched along with Kahler Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, HJ; Rundles, RW | 1 |
| Andriole, VT; Kundargi, RS; Mangi, RJ; Quintiliani, R | 1 |
2 other study(ies) available for cephalothin and Kahler Disease
| Article | Year |
|---|---|
Managing the complications of plasma cell myeloma.
Topics: Acute Kidney Injury; Bacterial Infections; Blood Urea Nitrogen; Blood Viscosity; Bone Neoplasms; Cephalothin; Cyclophosphamide; Cytarabine; Female; Fluoxymesterone; Furosemide; Gentamicins; Humans; Hypercalcemia; Kidney Failure, Chronic; Male; Melphalan; Middle Aged; Multiple Myeloma; Neurologic Manifestations; Plicamycin; Renal Dialysis | 1975 |
Development of meningitis during cephalothin therapy.
Topics: Adult; Aged; Blood-Brain Barrier; Cephalothin; Cholecystitis; Female; Humans; Klebsiella Infections; Male; Meningitis; Meningitis, Listeria; Meningitis, Meningococcal; Meningitis, Pneumococcal; Middle Aged; Multiple Myeloma; Sepsis | 1973 |